{"title":"阿奇霉素和羟氯喹治疗疑似SARS-COV-2病毒感染后健康人口腔白色念珠菌感染对氟康唑和制霉菌素的耐药性","authors":"M. El-Ansary, Amira R. El-Ansary","doi":"10.21608/ejmm.2023.277777","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"37 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Resistance of Oral Candida albicans Infection to Fluconazole and Nystatin among Healthy Persons after Treatment with Azithromycin and Hydroxychloroquine to Treat Suspected SARS-COV-2 Viral Infection\",\"authors\":\"M. El-Ansary, Amira R. El-Ansary\",\"doi\":\"10.21608/ejmm.2023.277777\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":22549,\"journal\":{\"name\":\"The Egyptian Journal of Medical Microbiology\",\"volume\":\"37 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Egyptian Journal of Medical Microbiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/ejmm.2023.277777\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Egyptian Journal of Medical Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/ejmm.2023.277777","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Resistance of Oral Candida albicans Infection to Fluconazole and Nystatin among Healthy Persons after Treatment with Azithromycin and Hydroxychloroquine to Treat Suspected SARS-COV-2 Viral Infection